Stay updated on NEOMUN Trial: Anti-PD-1 in Resectable Lung Cancer
Sign up to get notified when there's something new on the NEOMUN Trial: Anti-PD-1 in Resectable Lung Cancer page.

Latest updates to the NEOMUN Trial: Anti-PD-1 in Resectable Lung Cancer page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedIntroducing a government funding status notice and a new version tag (v3.2.0) with removal of the previous version (v3.1.0).SummaryDifference3%
- Check25 days agoChange DetectedPage revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive content changes.SummaryDifference0.1%
- Check39 days agoChange DetectedUpdated page revision from v3.0.1 to v3.0.2 and removed the 'Back to Top' link.SummaryDifference0.2%
- Check46 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.2%
- Check54 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, while key topics related to lung cancer and pharmacological action have been removed.SummaryDifference3%
- Check68 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to NEOMUN Trial: Anti-PD-1 in Resectable Lung Cancer
Enter your email address, and we'll notify you when there's something new on the NEOMUN Trial: Anti-PD-1 in Resectable Lung Cancer page.